Seeplex® Leukemia BCR/ABL detects 8 types of the BCR/ABL fusion gene simultaneously with a single reaction after cDNA synthesis using DPO™ technology, which maximizes specificity and sensitivity.
Features
-
Multiplex PCR
8 BCR/ABL gene rearrangement test using single PCR after the reverse transcription.
-
Reduction Contamination risk
A single round PCR process and 8-MOP reduces the carryover contamination risk
-
Validated process control
Accurate system for result interpretation included Internal Control
-
Informative assay
Assistant of appropriate treatment and management for co-infection
-
Powerful performance with unique technology
Multiplex PCR with high sensitivity and specificity by utilization of DPO™ technologies
-
Analytes
Seeplex®
Leukemia BCR/ABL
- b1a1
- b2a2
- b2a3
- b3a2
- b3a3
- c3a2
- e1a2
- e1a3
- Internal Control (IC)
-
Specimens
- Whole Blood
- Bone marrow
-
Ordering Information
ProductCat No. / SizeSeeplex® Leukemia BCR/ABLBC1110Z / 25 rxns
Result
| ID | Result |
|---|---|
| 1 | e1a2. |
| 2 | Not detected. |
| 3 | b3a2 |
| 4 | c3a2 |
| 5 | b2a2 |
| 6 | Not detected. |
| 7 | b2a2 |
1~7: Clinical samples
N: Negative Control
